Screener
Amneal Pharmaceuticals, Inc. AMRX PP&E (Net)
PP&E (Net) at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Prepaid expenses and other current assets | 112,011 | 98,395 |
| Related party receivables | 424 | 470 |
| Total current assets | 1,947,029 | 1,911,181 |
| Property, plant and equipment, net | 456,877 | 442,950 |
| Goodwill | 593,499 | 595,470 |
| Intangible assets, net | 587,830 | 563,498 |
| Operating lease right-of-use assets | 44,361 | 38,832 |
| Operating lease right-of-use assets - related party | 13,723 | 15,216 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s PP&E (net)?
- Amneal Pharmaceuticals, Inc. (AMRX) reported PP&E (net) of $456.88M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s PP&E (net) changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s PP&E (net) increased by 3.8% year-over-year, from $440.33M to $456.88M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s PP&E (net)?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s PP&E (net) has grown at a -1.5% compound annual growth rate (CAGR), from $477.75M to $442.95M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Amneal Pharmaceuticals, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude